Medical Writing Trends in medical writing The medical writing landscape in China
front-coverpng

Volume 28, Issue 3 - Trends in medical writing

The medical writing landscape in China

Abstract

The Chinese medical regulatory writing and medical science writing landscapes are chang - ing rapidly. Changes in regulatory reforms continue as China further strives to align its pharmaceutical industry with the world, which necessitates collaborative writers who are capable of keeping up with both changes in regulations and innovative medicine. Medical science writing is dependent on the adaptation of the material to suit Chinese media platforms. Despite the vast differences in regulatory writing and medical science writing, the essential skills are similar – under - standing data and knowing one’s audience.

Download the full article

References

  1. McIntosch I. Broad-spectrum medical writer: Nature or nurture? TWS. 2009;13:7–8.
  2. The International Council for Harmonisation (ICH). The Association begins new work on medicines for children and better clinical trials and China Food and Drug Administration joins ICH. 2017; Montreal, Canada. ICH Press Release.
  3. Cooper J, Yang R, Wati H, Hirayama R, Lu B, Kang S, et al. Medical writing for submission to Asia-Pacific regulatory authorities. Medical Writing: The Backbone of Clinical Development. 2017: May: 1-8.
  4. National Medical Products Administration. Notice on the application of ICH Ssecondary guidelines (Notice No. 10, 2018). 2018 [cited 2019 Apr 5]. Available from: http://www.nmpa.gov.cn/ WS04/CL2182/300493.html.
  5. Center For Drug Evaluation. Notice on public solicitation for comments on technical specifications on eCTD and eCTD verification standards. 2019. [cited 2019 Apr 5]. Available from: http://www.cde.org.cn/news.do?method= viewInfoCommon&id=314816.
  6. National Medical Products Administration. NMPA announcement on the adjustment of procedures for investigational new drug application (Notice No. 50, 2018). 2018 [cited 2019 Apr 5]. Available from: http://www.nmpa.gov.cn/WS04/CL2111 /329716.html.
  7. National Medical Products Administration. NMPA circular on pre-IND communication and management (Notice No. 74, 2018). 2018. [cited 2019 Apr 5]. Available from: http://www.nmpa.gov.cn/ WS04/CL2050/331245.html.
  8. Center For Drug Evaluation. Second announcement for urgent need of approved overseas drugs. 2019. [cited 2019 Apr 5]. Available from: http://www.cde.org.cn/ - news.do?method=viewInfoCommon&id= 314835.
  9. National Medical Products Administration. NMPA notice on the urgent need for approved overseas drugs (Notice No. 79, 2018). 2018. [cited 2019 Apr 5]. Available from: http://www.nmpa.gov.cn/ WS04/CL2050/331475.html.
  10. Wang M. Clinical trials and drug approvals continue to accelerate in China. Lancet Oncol. 2017;18(7):855.
  11. Miao R, Zhao J. A comparative study on popular science between China and the United States. 2016 International Symposium on Educational Technology (ISET); 2016 Jul 19-21; Beijing, China. Beijing: IEEE;2016. Conference paper.
  12. Miao R, Zhao J. A comparative study on popular science between China and the United States. 2016 International Symposium on Educational Technology (ISET); 2016 Jul 19-21; Beijing, China. Beijing: IEEE;2016. Conference paper.
  13. Yu L, Asur S, Huberman BA. What trends in Chinese social media. The 5th SNAKDD Workshop; 2011 Aug 21; San Diego, CA, USA. New York: ACM;2011. Conference paper.
  14. Liu G. Gary Liu: The rapid growth of the Chinese internet – and where it’s headed [Internet]. Location: TED; 2018. Available from: https://www.ted.com/talks/gary_liu_the_ rapid_growth_of_the_chinese_internet_ and_where_it_s_headed.

Search

Articles

Introduction
President's Message
EMWA News
Omics in silico and other trends in biomedical research: Impact on how and what we write
Catching the wave of lifestyle medicine
Artificial intelligence – will we be replaced by robots?
Now more than ever, scientists must speak up for science
When less is more: Medical writers as guardians of curated content
Predatory publishing – what medical communicators need to know
AMWA – EMWA – ISMPP Joint Position Statement on Predatory Publishing
How to combat medical misinformation with a sound content strategy
Subcontracting: Not for the faint of heart
Lay summaries and writing for patients: Where are we now and where are we going?
Clinical trial disclosure: Perspective from a medical writer for a contract research organisation
The 360° approach to authoring risk management plans
Trends in regulatory writing: A brief overview for aspiring medical writers
The medical writing landscape in China
News from the EMA
Regulatory Matters
Medical Communications and Writing for Patients
In the Bookstores
Getting Your Foot in the Door
Veterinary Medical Writing
Medical Devices
My First Medical Writing
Journal Watch
Good Writing Practice
Regulatory Public Disclosure
Out on Our Own

Member Login

Links

The Write Stuff Archive Contact Instructions for Authors Feature Article Template (Word) Journal Policies

Editoral Board

Editor-in-Chief:

Co-Editor:

Managing Editor

show all +

Associate Editors:

Section Editors:

Ad-hoc Editors:

  • Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)

Editor Emeritus: